CRYSTAL OF SUBSTITUTED PIPERIDINE COMPOUND, SALTS OF SUBSTITUTED PIPERIDINE COMPOUND, AND CRYSTALS THEREOF

Title:

CRYSTAL OF SUBSTITUTED PIPERIDINE COMPOUND, SALTS OF SUBSTITUTED PIPERIDINE COMPOUND, AND CRYSTALS THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/136279

Kind Code:

A1

Abstract:

Provided are a crystal of a compound represented by formula (I) that can be used as an active pharmaceutical ingredient of a drug, salts of the compound represented by formula (I), and crystals thereof.

More Like This:

JP2018522823	Bruton's tyrosine kinase inhibitor
JP3363448	INDUSTRIAL APPLICABILITY [Title of Invention] Piperidinyl-Terminated N- (Dihydroxyalkyl) -Etinylalanine Amide for the Treatment of Hypertension
WO/1996/011192	LTA4 HYDROLASE INHIBITORS

Inventors:

KUSHIDA IKUO (JP)
ITO YOKO (JP)
YASUI SO (JP)
FUKUYAMA TAKASHI (JP)
SATO NOBUAKI (JP)
ASABA TARO (JP)

Application Number:

PCT/JP2023/000561

Publication Date:

July 20, 2023

Filing Date:

January 12, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

EISAI R&D MAN CO LTD (JP)

International Classes:

C07D451/02; A61K31/506; A61P25/00; A61P43/00

Domestic Patent References:

WO2022014680A1	2022-01-20
WO2020122093A1	2020-06-18

Foreign References:

JP2016512536A

2016-04-28

Other References:

JANA JANOCKOVA, ET AL: "Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods", MOLECULES, vol. 23, no. 11, 1 January 2018 (2018-01-01), pages 2926, XP055720169, DOI: 10.3390/molecules23112926

Attorney, Agent or Firm:

HASEGAWA Yoshiki et al. (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR PRODUCING THREE-DIMENSIONAL CELL TISSUE

Next Patent: GRANULATING AGENT FOR FRESH CONCRETE